<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37529039</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Phenotypic and proteomic analysis of plasma extracellular vesicles highlights them as potential biomarkers of primary Sj&#xf6;gren syndrome.</ArticleTitle><Pagination><StartPage>1207545</StartPage><MedlinePgn>1207545</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1207545</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1207545</ELocationID><Abstract><AbstractText>Sj&#xf6;gren syndrome (SjS) is an autoimmune disease characterized by the destruction of the exocrine gland epithelia, causing a dryness of mucosa called sicca symptoms, and whose main life-threatening complication is lymphoma. There is a need for new biomarkers in this disease, notably diagnostic biomarkers for patients with genuine sicca symptoms that do not meet current criteria, and prognostic biomarkers for patients at risk of lymphoma. Plasma extracellular vesicles (EVs) are promising biomarker candidates in several diseases, but their potential has not yet been explored in SjS. In this proof-of-concept study, we characterized EVs from primary SjS patients (pSS, n=12) at the phenotypic and proteomic levels, compared to EVs from healthy donor (HD, n=8) and systemic lupus erythematosus patients (SLE, n=12). Specific plasma EVs subpopulations, derived from neutrophils, endothelial, and epithelial cells, were found increased in pSS. We also identified a pSS proteomic signature in plasma EVs, including neutrophil-, epithelial-, and endothelial-related proteins, such as integrin alpha M (ITGAM), olfactomedin-4 (OLFM4), Ras-related protein RAB10, and CD36. Overall, our results support the relevance of plasma EVs as biomarkers in SjS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Ferrant, Pontis, Zimmermann, Dingli, Poullet, Loew, Tarte and Dumontet.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferrant</LastName><ForeName>Juliette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>P&#xf4;le Biologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR, Universit&#xe9; Rennes, INSERM, &#xc9;tablissement Fran&#xe7;ais du Sang, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pontis</LastName><ForeName>Adeline</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>P&#xf4;le Biologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmermann</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de M&#xe9;decine Interne et Immunologie Clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dingli</LastName><ForeName>Florent</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institut Curie, PSL Research University, CurieCoreTech Mass Spectrometry Proteomics, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poullet</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institut Curie, PSL Research University, INSERM, Mines Paris Tech, Bioinformatics core facility (CUBIC), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loew</LastName><ForeName>Damarys</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institut Curie, PSL Research University, CurieCoreTech Mass Spectrometry Proteomics, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarte</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>P&#xf4;le Biologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR, Universit&#xe9; Rennes, INSERM, &#xc9;tablissement Fran&#xe7;ais du Sang, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumontet</LastName><ForeName>Erwan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>P&#xf4;le Biologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR, Universit&#xe9; Rennes, INSERM, &#xc9;tablissement Fran&#xe7;ais du Sang, Rennes, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008223" MajorTopicYN="Y">Lymphoma</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sj&#xf6;gren syndrome</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">extracellular vesicles</Keyword><Keyword MajorTopicYN="N">proteomic</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>3</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37529039</ArticleId><ArticleId IdType="pmc">PMC10388367</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1207545</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brito-Zer&#xf3;n P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. . Sj&#xf6;gren syndrome. Nat Rev Dis Primers (2016) 2:1&#x2013;20. doi:&#xa0;10.1038/nrdp.2016.47</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.47</ArticleId><ArticleId IdType="pubmed">27383445</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzis L, Pezoulas VC, Ferro F, Gandolfo S, Donati V, Binutti M, et al. . Sj&#xf6;gren&#x2019;s syndrome: the clinical spectrum of Male patients. J Clin Med (2020) 9:E2620. doi:&#xa0;10.3390/jcm9082620</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082620</ArticleId><ArticleId IdType="pmc">PMC7463756</ArticleId><ArticleId IdType="pubmed">32806710</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Casals M, Brito-Zer&#xf3;n P, Bombardieri S, Bootsma H, De Vita S, D&#xf6;rner T, et al. . EULAR recommendations for the management of sj&#xf6;gren&#x2019;s syndrome with topical and systemic therapies. Ann Rheum Dis (2020) 79:3&#x2013;18. doi:&#xa0;10.1136/annrheumdis-2019-216114</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-216114</ArticleId><ArticleId IdType="pubmed">31672775</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariette X, Criswell LA. Primary sj&#xf6;gren&#x2019;s syndrome. N Engl J Med (2018) 378:931&#x2013;9. doi:&#xa0;10.1056/NEJMcp1702514</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp1702514</ArticleId><ArticleId IdType="pubmed">29514034</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzis L, Vlachoyiannopoulos PG, Tzioufas AG, Goules AV. New frontiers in precision medicine for sjogren&#x2019;s syndrome. Expert Rev Clin Immunol (2021) 17:127&#x2013;41. doi:&#xa0;10.1080/1744666X.2021.1879641</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2021.1879641</ArticleId><ArticleId IdType="pubmed">33478279</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzas EI. The roles of extracellular vesicles in the immune system. Nat Rev Immunol (2023) 23:236&#x2013;50. doi:&#xa0;10.1038/s41577-022-00763-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00763-8</ArticleId><ArticleId IdType="pmc">PMC9361922</ArticleId><ArticleId IdType="pubmed">35927511</ArticleId></ArticleIdList></Reference><Reference><Citation>van Niel G, D&#x2019;Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol (2018) 19:213&#x2013;28. doi:&#xa0;10.1038/nrm.2017.125</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.125</ArticleId><ArticleId IdType="pubmed">29339798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN. Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum (2005) 52:1517&#x2013;21. doi:&#xa0;10.1002/art.21005</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21005</ArticleId><ArticleId IdType="pubmed">15880835</ArticleId></ArticleIdList></Reference><Reference><Citation>Aqrawi LA, Galtung HK, Vestad B, &#xd8;vsteb&#xf8; R, Thiede B, Rusthen S, et al. . Identification of potential saliva and tear biomarkers in primary sj&#xf6;gren&#x2019;s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis. Arthritis Res Ther (2017) 19:14. doi:&#xa0;10.1186/s13075-017-1228-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-017-1228-x</ArticleId><ArticleId IdType="pmc">PMC5264463</ArticleId><ArticleId IdType="pubmed">28122643</ArticleId></ArticleIdList></Reference><Reference><Citation>Aqrawi LA, Galtung HK, Guerreiro EM, &#xd8;vsteb&#xf8; R, Thiede B, Utheim TP, et al. . Proteomic and histopathological characterisation of sicca subjects and primary sj&#xf6;gren&#x2019;s syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers. Arthritis Res Ther (2019) 21:181. doi:&#xa0;10.1186/s13075-019-1961-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-1961-4</ArticleId><ArticleId IdType="pmc">PMC6670195</ArticleId><ArticleId IdType="pubmed">31366407</ArticleId></ArticleIdList></Reference><Reference><Citation>Alevizos I, Alexander S, Turner RJ, Illei GG. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in sj&#xf6;gren&#x2019;s syndrome. Arthritis Rheum (2011) 63:535&#x2013;44. doi:&#xa0;10.1002/art.30131</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.30131</ArticleId><ArticleId IdType="pmc">PMC3653295</ArticleId><ArticleId IdType="pubmed">21280008</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael A, Bajracharya SD, Yuen PST, Zhou H, Star RA, Illei GG, et al. . Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis (2010) 16:34&#x2013;8. doi:&#xa0;10.1111/j.1601-0825.2009.01604.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1601-0825.2009.01604.x</ArticleId><ArticleId IdType="pmc">PMC2844919</ArticleId><ArticleId IdType="pubmed">19627513</ArticleId></ArticleIdList></Reference><Reference><Citation>Finamore F, Cecchettini A, Ceccherini E, Signore G, Ferro F, Rocchiccioli S, et al. . Characterization of extracellular vesicle cargo in sj&#xf6;gren&#x2019;s syndrome through a SWATH-MS proteomics approach. Int J Mol Sci (2021) 22:4864. doi:&#xa0;10.3390/ijms22094864</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094864</ArticleId><ArticleId IdType="pmc">PMC8124455</ArticleId><ArticleId IdType="pubmed">34064456</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoloni E, Alunno A, Bistoni O, Caterbi S, Luccioli F, Santoboni G, et al. . Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary sj&#xf6;gren&#x2019;s syndrome: new markers of chronic endothelial damage? Rheumatol (Oxford) (2015) 54:536&#x2013;44. doi:&#xa0;10.1093/rheumatology/keu320</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu320</ArticleId><ArticleId IdType="pubmed">25190637</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellam J, Proulle V, J&#xfc;ngel A, Ittah M, Miceli Richard C, Gottenberg J-E, et al. . Increased levels of circulating microparticles in primary sj&#xf6;gren&#x2019;s syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther (2009) 11:R156. doi:&#xa0;10.1186/ar2833</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2833</ArticleId><ArticleId IdType="pmc">PMC2787287</ArticleId><ArticleId IdType="pubmed">19832990</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. . Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles (2018) 7:1535750. doi:&#xa0;10.1080/20013078.2018.1535750</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2018.1535750</ArticleId><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ing AN, van der Pol E, Grootemaat AE, Coumans FAW, Sturk A, Nieuwland R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracellular Vesicles (2014) 3:23430. doi:&#xa0;10.3402/jev.v3.23430</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v3.23430</ArticleId><ArticleId IdType="pmc">PMC4159761</ArticleId><ArticleId IdType="pubmed">25279113</ArticleId></ArticleIdList></Reference><Reference><Citation>Poullet P, Carpentier S, Barillot E. myProMS, a web server for management and validation of mass spectrometry-based proteomic data. Proteomics (2007) 7:2553&#x2013;6. doi:&#xa0;10.1002/pmic.200600784</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200600784</ArticleId><ArticleId IdType="pubmed">17610305</ArticleId></ArticleIdList></Reference><Reference><Citation>The M, MacCoss MJ, Noble WS, K&#xe4;ll L. Fast and accurate protein false discovery rates on Large-scale proteomics data sets with percolator 3.0. J Am Soc Mass Spectrom (2016) 27:1719&#x2013;27. doi:&#xa0;10.1007/s13361-016-1460-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13361-016-1460-7</ArticleId><ArticleId IdType="pmc">PMC5059416</ArticleId><ArticleId IdType="pubmed">27572102</ArticleId></ArticleIdList></Reference><Reference><Citation>Valot B, Langella O, Nano E, Zivy M. MassChroQ: a versatile tool for mass spectrometry quantification. Proteomics (2011) 11:3572&#x2013;7. doi:&#xa0;10.1002/pmic.201100120</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201100120</ArticleId><ArticleId IdType="pubmed">21751374</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics (2014) 13:2513&#x2013;26. doi:&#xa0;10.1074/mcp.M113.031591</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M113.031591</ArticleId><ArticleId IdType="pmc">PMC4159666</ArticleId><ArticleId IdType="pubmed">24942700</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva JC, Gorenstein MV, Li G-Z, Vissers JPC, Geromanos SJ. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics (2006) 5:144&#x2013;56. doi:&#xa0;10.1074/mcp.M500230-MCP200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M500230-MCP200</ArticleId><ArticleId IdType="pubmed">16219938</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwanh&#xe4;usser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al. . Global quantification of mammalian gene expression control. Nature (2011) 473:337&#x2013;42. doi:&#xa0;10.1038/nature10098</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10098</ArticleId><ArticleId IdType="pubmed">21593866</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahrn&#xe9; E, Molzahn L, Glatter T, Schmidt A. Critical assessment of proteome-wide label-free absolute abundance estimation strategies. Proteomics (2013) 13:2567&#x2013;78. doi:&#xa0;10.1002/pmic.201300135</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201300135</ArticleId><ArticleId IdType="pubmed">23794183</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifay A, Robert S, Champagne B, Petit P, Eug&#xe8;ne A, Chareyre C, et al. . A new strategy to count and sort neutrophil-derived extracellular vesicles: validation in infectious disorders. J Extracell Vesicles (2022) 11:e12204. doi:&#xa0;10.1002/jev2.12204</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12204</ArticleId><ArticleId IdType="pmc">PMC8971553</ArticleId><ArticleId IdType="pubmed">35362257</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Kindi MA, Colella AD, Chataway TK, Jackson MW, Wang JJ, Gordon TP. Secreted autoantibody repertoires in sj&#xf6;gren&#x2019;s syndrome and systemic lupus erythematosus: a proteomic approach. Autoimmun Rev (2016) 15:405&#x2013;10. doi:&#xa0;10.1016/j.autrev.2016.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2016.01.008</ArticleId><ArticleId IdType="pubmed">26804757</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan GJM, Miles K, Capitani L, Giguere SSB, Johnsson H, Goodyear C, et al. . In human autoimmunity, a substantial component of the b cell repertoire consists of polyclonal, barely mutated IgG+ve b cells. Front Immunol (2020) 11:395. doi:&#xa0;10.3389/fimmu.2020.00395</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00395</ArticleId><ArticleId IdType="pmc">PMC7099054</ArticleId><ArticleId IdType="pubmed">32265907</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyatt AR, Cater JH, Ranson M. PZP and PAI-2: structurally-diverse, functionally similar pregnancy proteins? Int J Biochem Cell Biol (2016) 79:113&#x2013;7. doi:&#xa0;10.1016/j.biocel.2016.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2016.08.018</ArticleId><ArticleId IdType="pubmed">27554634</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua CEL, Tang BL. Rab 10-a traffic controller in multiple cellular pathways and locations. J Cell Physiol (2018) 233:6483&#x2013;94. doi:&#xa0;10.1002/jcp.26503</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26503</ArticleId><ArticleId IdType="pubmed">29377137</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YM. CD36, a scavenger receptor implicated in atherosclerosis. Exp Mol Med (2014) 46:e99. doi:&#xa0;10.1038/emm.2014.38</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.38</ArticleId><ArticleId IdType="pmc">PMC4081553</ArticleId><ArticleId IdType="pubmed">24903227</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Rodgers GP. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer. Cancer Metastasis Rev (2016) 35:201&#x2013;12. doi:&#xa0;10.1007/s10555-016-9624-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10555-016-9624-2</ArticleId><ArticleId IdType="pubmed">27178440</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnsen KB, Gudbergsson JM, Andresen TL, Simonsen JB. What is the blood concentration of extracellular vesicles? implications for the use of extracellular vesicles as blood-borne biomarkers of cancer. Biochim Biophys Acta (BBA) - Rev Cancer (2019) 1871:109&#x2013;16. doi:&#xa0;10.1016/j.bbcan.2018.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2018.11.006</ArticleId><ArticleId IdType="pubmed">30528756</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuana Y, Levels J, Grootemaat A, Sturk A, Nieuwland R. Co-Isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation. J Extracell Vesicles (2014) 3:10. doi:&#xa0;10.3402/jev.v3.23262</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v3.23262</ArticleId><ArticleId IdType="pmc">PMC4090368</ArticleId><ArticleId IdType="pubmed">25018865</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Gutierrez L, Wilson R, Castelino M, Jury EC, Ciurtin C. Multi-omic biomarkers for patient stratification in sjogren&#x2019;s syndrome&#x2013;a review of the literature. Biomedicines (2022) 10:1773. doi:&#xa0;10.3390/biomedicines10081773</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10081773</ArticleId><ArticleId IdType="pmc">PMC9332255</ArticleId><ArticleId IdType="pubmed">35892673</ArticleId></ArticleIdList></Reference><Reference><Citation>Das N, Menon NG, de Almeida LGN, Woods PS, Heynen ML, Jay GD, et al. . Proteomics analysis of tears and saliva from sjogren&#x2019;s syndrome patients. Front Pharmacol (2021) 12:787193. doi:&#xa0;10.3389/fphar.2021.787193</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.787193</ArticleId><ArticleId IdType="pmc">PMC8689002</ArticleId><ArticleId IdType="pubmed">34950038</ArticleId></ArticleIdList></Reference><Reference><Citation>Hynne H, Aqrawi LA, Jensen JL, Thiede B, Palm &#xd8;, Amdal CD, et al. . Proteomic profiling of saliva and tears in radiated head and neck cancer patients as compared to primary sj&#xf6;gren&#x2019;s syndrome patients. IJMS (2022) 23:3714. doi:&#xa0;10.3390/ijms23073714</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23073714</ArticleId><ArticleId IdType="pmc">PMC8998953</ArticleId><ArticleId IdType="pubmed">35409074</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Wu X, Zhang S, Deng C, Zhao L, Wang M, et al. . The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary sj&#xf6;gren&#x2019;s syndrome. Arthritis Res Ther (2022) 24:170. doi:&#xa0;10.1186/s13075-022-02860-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-022-02860-4</ArticleId><ArticleId IdType="pmc">PMC9295258</ArticleId><ArticleId IdType="pubmed">35854322</ArticleId></ArticleIdList></Reference><Reference><Citation>Botha J, Handberg A, Simonsen JB. Lipid-based strategies used to identify extracellular vesicles in flow cytometry can be confounded by lipoproteins: evaluations of annexin V, lactadherin, and detergent lysis. J Extracell Vesicles (2022) 11:e12200. doi:&#xa0;10.1002/jev2.12200</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12200</ArticleId><ArticleId IdType="pmc">PMC8971177</ArticleId><ArticleId IdType="pubmed">35362259</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>